153 related articles for article (PubMed ID: 14996709)
1. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
McManus DT; Olaru A; Meltzer SJ
Cancer Res; 2004 Mar; 64(5):1561-9. PubMed ID: 14996709
[TBL] [Abstract][Full Text] [Related]
2. A predictive Bayesian network that risk stratifies patients undergoing Barrett's surveillance for personalized risk of developing malignancy.
Bradley A; Sami S; N G H; Macleod A; Prasanth M; Zafar M; Hemadasa N; Neagle G; Rosindell I; Apollos J
PLoS One; 2020; 15(10):e0240620. PubMed ID: 33045017
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.
Cook MB; Thrift AP
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):1-26. PubMed ID: 33213789
[TBL] [Abstract][Full Text] [Related]
4. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Reid BJ; Li X; Galipeau PC; Vaughan TL
Nat Rev Cancer; 2010 Feb; 10(2):87-101. PubMed ID: 20094044
[TBL] [Abstract][Full Text] [Related]
5. Alternatives to Traditional Per-Oral Endoscopy for Screening.
Offman J; Fitzgerald RC
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):379-396. PubMed ID: 28577763
[TBL] [Abstract][Full Text] [Related]
6. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL
PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966
[TBL] [Abstract][Full Text] [Related]
7. Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.
Abrams JA; Appelman HD; Beer DG; Berry LD; Chak A; Falk GW; Fitzgerald RC; Ginsberg GG; Grady WM; Joshi BP; Lynch JP; Markowitz S; Richmond ES; Rustgi AK; Seibel EJ; Shaheen NJ; Shyr Y; Umar A; Wang KK; Wang TC; Wang TD; Yassin R
Gastroenterology; 2014 Jun; 146(7):1586-90. PubMed ID: 24768332
[No Abstract] [Full Text] [Related]
8. Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review.
Zhang Z; Curran G; Altinok Dindar D; Wu Y; Wu H; Sharpton T; Zhao L; Lieberman D; Otaki F
Clin Transl Gastroenterol; 2021 Aug; 12(9):e00390. PubMed ID: 34446641
[TBL] [Abstract][Full Text] [Related]
9. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract][Full Text] [Related]
10. Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.
Behrens A; Pech O; Graupe F; May A; Lorenz D; Ell C
Dtsch Arztebl Int; 2011 May; 108(18):313-9. PubMed ID: 21629515
[TBL] [Abstract][Full Text] [Related]
11. Estimated Burden of Screening for Barrett's Esophagus in the United States.
Chandar AK; Low EE; Singer ME; Yadlapati R; Singh S
Gastroenterology; 2023 Jul; 165(1):283-285.e2. PubMed ID: 37001765
[No Abstract] [Full Text] [Related]
12. TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
Rubenstein JH; Stachler MD
Gastroenterology; 2023 Nov; 165(5):1106-1107. PubMed ID: 37659675
[No Abstract] [Full Text] [Related]
13. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract][Full Text] [Related]
14. Comments on "TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?".
Duits LC; Critchley-Thorne RJ; Bergman JJGHM
Gastroenterology; 2024 Apr; 166(4):714-715. PubMed ID: 38109947
[No Abstract] [Full Text] [Related]
15. If Pills Don't Work, Try Staples: Surgery for Barrett's Esophagus Complicating Progressive Systemic Sclerosis.
Braghetto I; Triadafilopoulos G; de Paula GA; Hevia M; Lanzarini E; Figueredo E; Durand L; Korn O
Dig Dis Sci; 2023 Oct; 68(10):3879-3885. PubMed ID: 37634186
[No Abstract] [Full Text] [Related]
16. Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.
Kountourakis P; Ajani JA; Davila M; Lee JH; Bhutani MS; Izzo JG
Gastrointest Cancer Res; 2012 Mar; 5(2):49-57. PubMed ID: 22690258
[TBL] [Abstract][Full Text] [Related]
17. Surrogate Markers: Lessons from the Next Gen?
Reid BJ
Cancer Prev Res (Phila); 2016 Jul; 9(7):512-7. PubMed ID: 27138791
[TBL] [Abstract][Full Text] [Related]
18. Value of exhaled hydrogen sulfide in early diagnosis of esophagogastric junction adenocarcinoma.
Liu F; Wei L; Zheng B; Su X; Ju J; Liu G; Liu Q
Oncol Lett; 2024 Jul; 28(1):321. PubMed ID: 38807679
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C.
Yao W; Jia X; Xu L; Li S; Wei L
Cell Cycle; 2021 Jun; 20(12):1163-1172. PubMed ID: 34057012
[TBL] [Abstract][Full Text] [Related]
20. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
